Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Perceptions of Olopatadine 0.2% in Allergic Conjunctivitis
NCT01159769Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jun 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of olopatadine in allergic conjunctivitis (AC), sponsored by Alcon Inc.. Started Jun 2010; status: completed.
02
Drugs
olopatadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01159769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159769.